In the News

1855 News Items found
Memorial Sloan Kettering Cancer Center (MSK) has been ranked as the number two hospital for cancer care in the nation, according to <i>U.S. News & World Report</i> in its annual listing of Best Hospitals. Since the inception of the rankings 30 years ago, MSK has held either the first or second spot each year for cancer care. MSK was also ranked first in gynecology.
Memorial Sloan Kettering Cancer Center (MSK) researchers published new results that found that individuals with low-risk or intermediate-risk myeloma precursor disease known as monoclonal gammopathy of undetermined significance (MGUS) can convert to high-risk MGUS and progress to multiple myeloma within a five-year window. This research clinically supports recommendations for annual blood tests for all individuals diagnosed with MGUS along with re-assessments of a patient’s clinical-risk status. Their research was published today online in <i>JAMA Oncology</i>.
Green and blue blobs on a black background
In the Lab
Innovative imaging techniques shed light on intestinal damage that occurs after bone marrow transplant.
Doctor and patient
In the Clinic
Results from a study of women with breast and ovarian cancer show surprisingly low rates of genetic testing.
Thomas Fuchs
In the Lab
MSK researchers developed an artificial intelligence system to detect cancer on digitized microscope slides.
Computational biologist Barry Taylor
Finding
Sometimes a BRCA mutation is just along for the ride, rather than driving a tumor’s development.
Old man lying in hospital bed being spoken to by nurse
Q&A
An MSK geriatrician discusses the importance of helping older people with cancer manage their treatment and symptoms.
George Bosl
Announcement
Learn about George Bosl, who will become MSK's first ombudsperson.
Molecular image with target symbol
In the Lab
A new imaging technology developed at MSK allows researchers to focus on genes as they are copied into messenger RNA.
cartoon of man hitting a snooze button
In the Lab
An FDA-approved drug used to treat leukemia can serve as a temporary off switch for CAR T cells, MSK scientists have found.